References
- Aikin, K., Swasy, J. & Braman, A. (2004). Patient and physician attitudes and behaviors associated with direct to consumer promotion of prescription drugs: Summary of FDA survey research results. Retrieved from the U.S. Food and Drug Administration website: http://www.fda.gov/downloads/Drugs/ScienceResearch/ResearchAreas/DrugMarketingAdvertisingandCommunicationsResearch/UCM152860.pdf
- Betts, K. R. & Hinsz, V. B. (2013). Strong shared representations promote schema-consistent memory errors in groups. Group Processes & Intergroup Relations, 16(6), 734–751. doi:10.1177/1368430213486206
- Brownfield, E. D., Bernhardt, J. M., Phan, J. L., Williams, M. V. & Parker, R. M. (2004). Direct-to-consumer drug advertisements on network television: An exploration of quantity, frequency, and placement. Journal of Health Communication, 9(6), 491–497. doi:10.1080/10810730490523115
- Burke, R. R., DeSarbo, W. S., Oliver, R. L. & Robertson, T. S. (1988). Deception by implication: An experimental investigation. Journal of Consumer Research, 14, 483–494. doi:10.1086/209130
- Cegedim Strategic Data. (2013). 2012 U.S. pharmaceutical promotion spending. Retrieved from http://www.skainfo.com/health_care_market_reports/2012_promotional_spending.pdf
- Deshpande, A., Menon, A., Perri, M., III, & Zinkhan, G. (2004). Direct-to-consumer advertising and its utility in health care decision making: A consumer perspective. Journal of Health Communication, 9(6), 499–513. doi:10.1080/10810730490523197
- Dobrow, L. (2014). DTC report: DTC gets smart. Retrieved from http://www.mmm-online.com/dtc-report-dtc-gets-smart/article/339357/
- GfK Custom Research. (2013). Knowledge panel design summary report. Retrieved from http://www.knowledgenetworks.com/knpanel/docs/knowledgePanel%28R%29-design-summary-description.pdf
- Hall, D. V., Jones, S. C. & Hoek, J. (2011). Direct to consumer advertising versus disease awareness advertising: Consumer perspectives from down under. Journal of Public Affairs, 11(1), 60–69. doi:10.1002/pa.379
- Harris, R. J. (1977). Comprehension of pragmatic implications in advertising. Journal of Applied Psychology, 62(5), 603–608. doi:10.1037//0021-9010.62.5.603
- Jacoby, J. & Hoyer, W. D. (1987). The comprehension and miscomprehension of print communications: An investigation of mass media magazines. New York, NY: Routledge.
- Kravitz, R. L., Epstein, R. M., Feldman, M. D., Franz, C. E., Azari, R., Wilkes, M. S. & Franks, P. (2005). Influence of patients’ requests for direct-to-consumer advertised antidepressants: A randomized controlled trial. Journal of the American Medical Association, 293(16), 1995–2002. doi:10.1001/jama.293.16.1995
- Lee-Wingate, S. N. & Xie, Y. (2010). Consumer perceptions of product-claim versus help-seeking direct-to-consumer advertising. International Journal of Pharmaceutical and Healthcare Marketing, 4(3), 232–246. doi:10.1108/17506121011076165
- Lee-Wingate, S. N. & Xie, Y. (2013). The influence of the number of presented symptoms in product-claim direct-to-consumer advertising on behavioral intentions. International Journal of Pharmaceutical and Healthcare Marketing, 7(3), 265–284. doi:10.1108/ijphm-05-2013-0025
- Mendonca, C. M., McCaffrey, D. J., Banahan, B. F., Bentley, J. P. & Yang, Y. (2011). Effect of direct-to-consumer drug advertising exposure on information search. Drug Information Journal, 45(4), 503–515. doi:10.1177/009286151104500411
- Mintzes, B. (2012). Advertising of prescription-only medicines to the public: Does evidence of benefit counterbalance harm? Annual Review of Public Health, 33, 259–277. doi:10.1146/annurev-publhealth-031811-124540
- Palumbo, F. B. & Mullins, C. D. (2002). The development of direct-to-consumer prescription drug advertising regulation. Food & Drug Law Journal, 57, 423–444.
- Prescription Drug Advertising Regulations. (2014). 21 C.F.R. § 202.1.
- Rollins, B. L., King, K., Zinkhan, G. & Perri, M. (2010). Behavioral intentions and information-seeking behavior: A comparison of nonbranded versus branded direct-to-consumer prescription advertisements. Therapeutic Innovation & Regulatory Science, 44(6), 673–683. doi:10.1177/009286151004400603
- Rollins, B. L., King, K., Zinkhan, G. & Perri, M. (2011). Nonbranded or branded direct-to-consumer prescription drug advertising—Which is more effective? Health Marketing Quarterly, 28(1), 86–98. doi:10.1080/07359683.2011.545337
- U.S. Food and Drug Administration. (2005). Impact of direct-to-consumer drug advertising on seniors’ health and health care costs [Statement of Rachel E. Behrman before the Senate Special Committee on Aging]. Retrieved from http://www.fda.gov/newsevents/testimony/ucm112706.htm
- U.S. Food and Drug Administration. (2010). [Novartis oncology warning letter about Gleevec (imatinib mesylate)]. Retrieved from http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/ucm259229.htm
- U.S. Food and Drug Administration. (2014). Advertising and promotional labeling questions and answers. Retrieved from http://www.fda.gov/biologicsbloodvaccines/developmentapprovalprocess/advertisinglabelingpromotionalmaterials/ucm117616.htm
- Weissman, J. S., Blumenthal, D., Silk, A. J., Newman, M., Zapert, K., Leitman, R. & Feibelmann, S. (2004). Physicians report on patient encounters involving direct-to-consumer advertising. Health Affairs, W4-219–W4-233.
- Weissman, J. S., Blumenthal, D., Silk, A. J., Zapert, K., Newman, M. & Leitman, R. (2003). Consumers’ reports on the health effects of direct-to-consumer drug advertising. Health Affairs, W3-82–W3-95. doi:10.1377/hlthaff.w3.82
- Willis, G. B. (2005). Cognitive interviewing: A tool for improving questionnaire design. Thousand Oaks, CA: Sage.